UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characterisation of structurally modified analogues of glucagon as potential glucagon receptor antagonists

Molecular and cellular endocrinology, 2013-12, Vol.381 (1-2), p.26-34

2013

Volltextzugriff (PDF)

Additive hypoglycaemic effect of nateglinide and exogenous glucagon-like peptide-1 in type 2 diabetes

Diabetes research and clinical practice, 2011-03, Vol.91 (3), p.e68-e70

2011

Volltextzugriff (PDF)

Novel dual agonist peptide analogues derived from dogfish glucagon show promising in vitro insulin releasing actions and antihyperglycaemic activity in mice

Molecular and cellular endocrinology, 2016-08, Vol.431, p.133-144

2016

Volltextzugriff (PDF)

Administration of protein hydrolysates from Palmaria palmata reduced food intake, improved glycaemic parameters and lipid profile in streptozotocin diabetes induced mice

Proceedings of the Nutrition Society, 2018, Vol.77 (OCE3), Article E112

2018

Volltextzugriff (PDF)

Synthetic peptides identified from Palmaria palmata enhance glucagon-like peptide-1 stability in vitro and show acute anti-hyperglycaemic and insulinotropic actions in mice

Proceedings of the Nutrition Society, 2018, Vol.77 (OCE3), Article E113

2018

Volltextzugriff (PDF)

The effect of consuming boarfish protein hydrolysate on metabolic health in overweight adults

Proceedings of the Nutrition Society, 2018, Vol.77 (OCE3), Article E106

2018

Volltextzugriff (PDF)

Comparison of the independent and combined metabolic effects of subchronic modulation of CCK and GIP receptor action in obesity-related diabetes

International Journal of Obesity, 2013-08, Vol.37 (8), p.1058-1063

2013

Volltextzugriff (PDF)

The effect of boarfish protein hydrolysate on postprandial glycaemic response and satiety in healthy adults

Proceedings of the Nutrition Society, 2018, Vol.77 (OCE3), Article E105

2018

Volltextzugriff (PDF)

Effects of nateglinide on the secretion of glycated insulin and glucose tolerance in type 2 diabetes

Diabetes research and clinical practice, 2003-09, Vol.61 (3), p.167-173

2003

Volltextzugriff (PDF)

Apelin-13 analogues show potent in vitro and in vivo insulinotropic and glucose lowering actions

Peptides (New York, N.Y. : 1980), 2018-02, Vol.100, p.219-228

2018

Volltextzugriff (PDF)

In vitro bioactivity of central Ala-substituted GIP(1–42) analogues and their importance for structure function

Regulatory peptides, 2010-09, Vol.164 (1), p.42-42

2010

Volltextzugriff (PDF)

Miniglucagon and glucagon fragment peptides have differential effects on insulin secretion in cultured pancreatic beta cells

Regulatory peptides, 2010-09, Vol.164 (1), p.43-44

2010

Volltextzugriff (PDF)

Stability and efficacy studies in N-terminally truncated glucagon receptor antagonist peptides

Regulatory peptides, 2010-09, Vol.164 (1), p.41-42

2010

Volltextzugriff (PDF)

The novel (Pro3)glucagon-amide analogue antagonises the action of glucagon both in vitro and in vivo

Regulatory peptides, 2010-09, Vol.164 (1), p.42-42

2010

Volltextzugriff (PDF)

Evaluation of the inhibitory action of islet amyloid polypeptide on insulin secretion from clonal rat pancreatic beta-cells

Regulatory peptides, 2010-09, Vol.164 (1), p.44-44

2010

Volltextzugriff (PDF)

Peptide based glucagon analogues are effective agents in blocking the hyperglycaemic actions of glucagon in high fat fed mice

Regulatory peptides, 2010-09, Vol.164 (1), p.32-33

2010

Volltextzugriff (PDF)

DPP IV resistance and insulin releasing activity of a novel di-substituted analogue of glucose-dependent insulinotropic polypeptide, (Ser2–Asp13)GIP

Cell biology international, 2003-01, Vol.27 (1), p.41-46

2003

Volltextzugriff (PDF)

Cyclic AMP production and insulin releasing activity of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide

Bioscience reports, 2002-10, Vol.22 (5-6), p.523-528

2002

Volltextzugriff (PDF)

Evaluation of Glycated Insulin in Diabetic Animals Using Immunocytochemistry and Radioimmunoassay

Biochemical and biophysical research communications, 2001-08, Vol.286 (3), p.524-528

2001

Volltextzugriff (PDF)

Degradation and glycemic effects of His7-glucitol glucagon-like peptide-1(7-36)amide in obese diabetic ob/ob mice

Regulatory peptides, 2001, Vol.96 (3), p.95-104

2001

Volltextzugriff (PDF)

Comparative effects of GLP-1 and GIP on cAMP production, insulin secretion, and in vivo antidiabetic actions following substitution of Ala8/Ala2 with 2-aminobutyric acid

Archives of biochemistry and biophysics, 2004-08, Vol.428 (2), p.136-143

2004

Volltextzugriff (PDF)

Comparative effects of GLP-1 and GIP on cAMP production, insulin secretion, and in vivo antidiabetic actions following substitution of Ala 8/Ala 2 with 2-aminobutyric acid

Archives of biochemistry and biophysics, 2004, Vol.428 (2), p.136-143

2004

Volltextzugriff (PDF)

Structure, antihyperglycemic activity and cellular actions of a novel diglycated human insulin

Peptides (New York, N.Y. : 1980), 2000-10, Vol.21 (10), p.1519-1526

2000

Volltextzugriff (PDF)

Methylmalonic acid in the diagnosis of cobalt deficiency in barley-fed lambs

British journal of nutrition, 1989-11, Vol.62 (3), p.729-738

1989

Volltextzugriff (PDF)

Lys 9 for Glu 9 substitution in glucagon-like peptide-1(7–36)amide confers dipeptidylpeptidase IV resistance with cellular and metabolic actions similar to those of established antagonists glucagon-like peptide-1(9–36)amide and exendin (9–39)

Metabolism, clinical and experimental, 2004, Vol.53 (2), p.252-259

2004

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

Animals
(13)
Life Sciences & Biomedicine
(12)
Science & Technology
(12)
Diabetes
(9)
Endocrinology & Metabolism
(8)
Humans
(8)
Insulin - Metabolism
(8)
Male
(8)
Mice
(8)
Insulin Secretion
(7)
Biological And Medical Sciences
(6)
Glucose
(6)
Biochemistry & Molecular Biology
(5)
Glucose - Metabolism
(5)
Insulin
(5)
Islets Of Langerhans - Metabolism
(5)
Blood Glucose - Metabolism
(4)
Diabetes Mellitus, Type 2 - Drug Therapy
(4)
Glucagon
(4)
Medical Sciences
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Characterisation of structurally modified analogues of glucagon as potential glucagon receptor antagonists

Additive hypoglycaemic effect of nateglinide and exogenous glucagon-like peptide-1 in type 2 diabetes

Novel dual agonist peptide analogues derived from dogfish glucagon show promising in vitro insulin releasing actions and antihyperglycaemic activity in mice

Administration of protein hydrolysates from Palmaria palmata reduced food intake, improved glycaemic parameters and lipid profile in streptozotocin diabetes induced mice

Synthetic peptides identified from Palmaria palmata enhance glucagon-like peptide-1 stability in vitro and show acute anti-hyperglycaemic and insulinotropic actions in mice

The effect of consuming boarfish protein hydrolysate on metabolic health in overweight adults

Comparison of the independent and combined metabolic effects of subchronic modulation of CCK and GIP receptor action in obesity-related diabetes

The effect of boarfish protein hydrolysate on postprandial glycaemic response and satiety in healthy adults

Effects of nateglinide on the secretion of glycated insulin and glucose tolerance in type 2 diabetes

Apelin-13 analogues show potent in vitro and in vivo insulinotropic and glucose lowering actions

In vitro bioactivity of central Ala-substituted GIP(1–42) analogues and their importance for structure function

Miniglucagon and glucagon fragment peptides have differential effects on insulin secretion in cultured pancreatic beta cells

Stability and efficacy studies in N-terminally truncated glucagon receptor antagonist peptides

The novel (Pro3)glucagon-amide analogue antagonises the action of glucagon both in vitro and in vivo

Evaluation of the inhibitory action of islet amyloid polypeptide on insulin secretion from clonal rat pancreatic beta-cells

Peptide based glucagon analogues are effective agents in blocking the hyperglycaemic actions of glucagon in high fat fed mice

DPP IV resistance and insulin releasing activity of a novel di-substituted analogue of glucose-dependent insulinotropic polypeptide, (Ser2–Asp13)GIP

Cyclic AMP production and insulin releasing activity of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide

Evaluation of Glycated Insulin in Diabetic Animals Using Immunocytochemistry and Radioimmunoassay

Degradation and glycemic effects of His7-glucitol glucagon-like peptide-1(7-36)amide in obese diabetic ob/ob mice

Comparative effects of GLP-1 and GIP on cAMP production, insulin secretion, and in vivo antidiabetic actions following substitution of Ala8/Ala2 with 2-aminobutyric acid

Comparative effects of GLP-1 and GIP on cAMP production, insulin secretion, and in vivo antidiabetic actions following substitution of Ala 8/Ala 2 with 2-aminobutyric acid

Structure, antihyperglycemic activity and cellular actions of a novel diglycated human insulin

Methylmalonic acid in the diagnosis of cobalt deficiency in barley-fed lambs

Lys 9 for Glu 9 substitution in glucagon-like peptide-1(7–36)amide confers dipeptidylpeptidase IV resistance with cellular and metabolic actions similar to those of established antagonists glucagon-like peptide-1(9–36)amide and exendin (9–39)

Suchergebnisse filtern